Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Amgen submits sBLA for Enbrel in ankylosing spondylitis

Jan. 24, 2003

Celera patent covers the preparation and use of new cathepsin S inhibitors

Jan. 23, 2003

Three series of COX-2 inhibitors prepared and tested at GSK

Jan. 21, 2003

BMS scientists prepare new MMP, TACE and/or aggrecanase inhibitors

Jan. 20, 2003

Antiarthritic effects demonstrated for a selective CXCR2 antagonist

Jan. 17, 2003

Cytokine production inhibitors newly developed at Boehringer Ingelheim

Jan. 17, 2003

Prasterone to be reviewed by EMEA

Jan. 13, 2003

Novel cytokine inhibitors discovered by Procter & Gamble researchers

Jan. 10, 2003

Advances reported in Scios's p38 MAP kinase program

Jan. 9, 2003

Antagonists of migration-inhibitory factor (MIF) discovered at Avanir

Jan. 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...